文献速递生殖医学

早发性卵巢功能不全诊断后妊娠:一项系统综述

Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review.
PubMed 文献 · Reprod Biomed Online · 2019-04-30

本综述检索2000年1月至2018年1月MEDLINE、PubMed和Embase数据库,纳入15项研究(2项随机对照试验、2项观察性研究、11项干预性研究),报告早发性卵巢功能不全(POI)女性自然或经不同治疗后的妊娠情况,各研究妊娠率为2.2%至14.2%,实现妊娠者平均年龄30岁,目前尚无治疗显示在改善POI女性生育力方面具有优势。

要点

  • POI女性各研究妊娠率为2.2%至14.2%。
  • 实现妊娠者平均年龄30岁,提示卵母细胞质量可能未受影响。
  • 尚无治疗显示在改善POI女性生育力方面具有优势。

核心结论

  • 目前尚无治疗显示在改善POI女性生育力方面具有优势。
  • 体外成熟和干细胞治疗等选项的最新进展可能成为未来治疗方向,并可能为这些患者带来新希望。

研究设计与样本

  • 系统综述,检索MEDLINE、PubMed和Embase数据库2000年1月至2018年1月的文献。
  • 纳入15项研究,包括2项随机对照试验、2项观察性研究和11项干预性研究,报告POI女性妊娠病例。

主要发现

  • 各研究妊娠率范围为2.2%至14.2%。
  • 实现妊娠患者的平均年龄为30岁。

关键数值与推荐

  • 检索词包括「premature menopause」「premature ovarian failure」「POI」「hypergonadotrophic amenorrhoea」,并与「pregnancy」组合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this review is to report the occurrence of pregnancies in women with premature ovarian insufficiency (POI), naturally or with different treatments (hormonal replacement therapy, IVF, in-vitro maturation and stem cell therapy). This study involved an exhaustive search of the electronic databases MEDLINE, PubMed and Embase covering the period January 2000 to January 2018. A combination of Medical Subject Heading and text words was used to generate a subset of citations, including studies involving POI ('premature menopause' or 'premature ovarian failure' or 'POI' or 'hypergonadotrophic amenorrhoea'). This subset of citations was then combined with 'AND' to the Medical Subject Heading term 'pregnancy'. Fifteen studies were included in this review. Two randomized controlled trials, two observational studies, and 11 interventional studies reporting cases of pregnancy in women with POI were included. This review reports pregnancy rates across studies ranging from 2.2% to 14.2%. Mean age in patients who achieved a pregnancy was 30 years, highlighting that oocyte quality in these patients is likely unaffected. No treatment has thus far shown its superiority in improving fertility in women with POI. Recent advances in options such as in-vitro maturation and stem-cell therapy, however, are likely to be the future of treatment and may generate new hope for these patients.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Fraison E, Crawford G, Casper G, et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online. 2019. PMID: 31279714. doi:10.1016/j.rbmo.2019.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。